封面
市場調查報告書
商品編碼
1750688

醫藥分析測試外包市場規模、佔有率、趨勢分析報告:按服務、最終用途、地區、細分市場預測,2025-2030 年

Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

醫藥分析和測試外包市場的成長和趨勢

預計到 2030 年,全球醫藥分析測試外包市場規模將達到 145.6 億美元,2025 年至 2030 年的複合年成長率為 8.6%。

生物候選化合物的不斷增加、對藥物深度分析的需求日益成長以及監管機構的製程開發,正在推動市場的成長。分析測試不僅有助於即時產品品管,還有助於製程最佳化和監控,從而識別不同的藥物。多年來,臨床試驗的數量一直持續增加。

例如,2021 年在 ClinicalTrial.gov 上註冊的臨床試驗超過 399,525 項,但截至 2022 年 6 月,這一數字已增至 421,258 多項。預計這種趨勢的延續即使在疫情過後也將對市場產生正面影響。大多數中小型製藥公司缺乏分析測試的基礎設施。因此,將這些業務外包已成為最佳選擇,因為它可以節省時間和金錢。主要針對小分子和生技藥品的專利懸崖可能會促進對市售學名藥的分析測試,這將增加醫藥市場上上市藥品的數量,從而對市場產生積極影響。

自新冠疫情以來,多種疾病的發生率上升。例如,兒童國家醫院兒科研究與臨床創新中心發布的一份報告調查了737名確診患有糖尿病的青少年,發現在2018年3月11日至2021年3月10日期間,兒童1型糖尿病(T1D)的發病率增加了15.2%,2型糖尿病(T2D)的發病率增加了182%。疾病盛行率的上升預計將促進藥品生產,並可能推動對非處方藥分析服務的需求。

藥品分析測試外包市場報告重點

  • 生物分析測試領域將佔據市場主導地位,2024 年的收入佔有率將達到 38.44%。生物分析測試包括臨床測試和非臨床測試。
  • 2024 年,製藥業佔據了最大的市場佔有率。製藥公司對核心競爭力的關注度不斷提高,這是該行業佔最大佔有率的主要原因之一。
  • 由於北美地區擁有大量製藥公司,預計該地區將佔據最大的收益佔有率,為 52.91%。
  • 預計亞太地區將成為2025年至2030年間成長最快的區域市場,這得歸功於第三方服務供應商提供的低成本服務。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章。醫藥分析測試外包市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 臨床試驗量分析(2024年)
    • 各地區臨床試驗總數
    • 各階段臨床試驗總數
    • 按研究設計分類的臨床試驗總數
    • 按主要治療領域分類的臨床試驗總數
  • 定價模式分析
  • 科技
  • 市場分析工具
    • 波特五力分析
    • PESTEL 與 SWOT 分析
    • COVID-19影響分析

第4章:醫藥分析和測試外包市場:按服務分類的估計和趨勢分析

  • 醫藥分析測試外包市場(按服務):細分儀表板
  • 醫藥分析測試外包市場(按服務):波動分析
  • 按服務分類,2018-2030 年
  • 生物分析測試
    • 臨床
    • 非臨床
  • 方法開發和檢驗
    • 可萃取與可浸出
    • 雜質法
    • 技術諮詢
    • 其他
  • 穩定性測試
    • 藥物成分
    • 穩定性指標檢驗
    • 加速穩定性試驗
    • 光穩定性測試
    • 其他
  • 其他

第5章。醫藥分析測試外包市場:按最終用途的估計和趨勢分析

  • 醫藥分析測試外包市場(依最終用途):細分儀表板
  • 醫藥分析測試外包市場,依最終用途:變異分析
  • 依最終用途,2018-2030 年
  • 製藥公司
  • 生物製藥公司
  • 合約研究組織

第6章:醫藥分析和測試外包市場:按地區估計和趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 市場參與企業分類
  • 2024 年公司市場佔有率/估值分析
  • 公司簡介
    • SGS Societe Generale de Surveillance SA
    • Labcorp
    • Eurofins Scientific
    • Pace Analytical Services LLC
    • Intertek Group plc
    • PPD Inc(Thermo Fisher Scientific Inc.)
    • Wuxi AppTec
    • BA Sciences
    • Charles River Laboratories
    • West Pharmaceutical Services, Inc
Product Code: GVR-1-68038-365-2

Pharmaceutical Analytical Testing Outsourcing Market Growth & Trends:

The global pharmaceutical analytical testing outsourcing market size is estimated to reach USD 14.56 billion by 2030 and is projected to grow at a CAGR of 8.6% from 2025 to 2030. Increasing biological candidate pipelines, rising demand for additional analytical details on drugs, and process development by regulatory agencies are driving market growth. Analytical testing aids in real-time product quality control as well as help optimize and monitor processes, thereby identifying different drugs. Over the years, the number of clinical trials has increased consistently.

For instance, in 2021, over 399,525 clinical studies were registered on ClinicalTrial.gov, whereas as of June 2022, it had increased to over 421,258 studies. A continuation of this trend is expected to have a positive impact on the market in the post-pandemic period. The majority of small and medium-sized pharma companies lack the infrastructure for analytical testing. As a result, outsourcing these operations is the best option as it saves time and money. The patent cliff, primarily for small molecules and biologics, is likely to have a positive impact on the market as it will increase the number of commercial drugs in the pharma market, thus promoting the analytical testing of commercially available generic drugs.

There has been a rise in several diseases post-COVID-19. For instance, according to a report published by Children's National Hospital- pediatric research and clinical innovations center, a study was performed on 737 youths who were diagnosed with diabetes, and it found an increased incidence of pediatric Type 1 Diabetes (T1D) by 15.2% and Type 2 Diabetes (T2D) increased by 182% between March 11, 2018, and March 10, 2021. The rise in disease incidence is expected to improve, drug production, which is likely to drive the demand for analytical services for commercial drugs .

Pharmaceutical Analytical Testing Outsourcing Market Report Highlights:

  • The bioanalytical testing segment dominated the market, accounting for a revenue share of 38.44% in 2024. Bioanalytical testing covers both clinical and non-clinical studies.
  • The pharmaceutical segment gained the largest market share in 2024. The growing demand among pharmaceutical companies to focus on their core competencies is one of the major reasons for the largest segment share.
  • North America is expected to hold the largest revenue share of 52.91% owing to the presence of a significant number of pharmaceutical companies in the region.
  • Asia Pacific is anticipated to be the fastest-growing regional market from 2025 to 2030 due to the low-cost service offerings by third-party service providers in the region.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Analytical Testing Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Clinical Trials Volume Analysis, (2024)
    • 3.3.1. Total Number Of Clinical Trials By Region
    • 3.3.2. Total Number Of Clinical Trials, By Phase
    • 3.3.3. Total Number Of Clinical Trials, By Study Design
    • 3.3.4. Total Number Of Clinical Trials, By Key Therapeutic Area
  • 3.4. Pricing Model Analysis
  • 3.5. Technology Landscape
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL by SWOT Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Analytical Testing Outsourcing Market: Service Estimates & Trend Analysis

  • 4.1. Pharmaceutical Analytical Testing Outsourcing Market, By Service: Segment Dashboard
  • 4.2. Pharmaceutical Analytical Testing Outsourcing Market, By Service: Movement Analysis
  • 4.3. Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
  • 4.4. Bioanalytical Testing
    • 4.4.1. Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Clinical
      • 4.4.2.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Non-Clinical
      • 4.4.3.1. Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Method Development & Validation
    • 4.5.1. Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Extractable & Leachable
      • 4.5.2.1. Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Impurity Method
      • 4.5.3.1. Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Technical Consulting
      • 4.5.4.1. Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Stability Testing
    • 4.6.1. Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Drug Substance
      • 4.6.2.1. Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Stability Indicating Method Validation
      • 4.6.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Accelerated Stability Testing
      • 4.6.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Photostability Testing
      • 4.6.5.1. Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. Others
      • 4.6.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Analytical Testing Outsourcing Market: End Use Estimates & Trend Analysis

  • 5.1. Pharmaceutical Analytical Testing Outsourcing Market, By End Use: Segment Dashboard
  • 5.2. Pharmaceutical Analytical Testing Outsourcing Market, By End Use: Movement Analysis
  • 5.3. Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 5.4. Pharmaceutical Companies
    • 5.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Biopharmaceutical Companies
    • 5.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Contract Research Organizations
    • 5.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Analytical Testing Outsourcing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. North America
    • 6.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.S
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Framework
      • 6.4.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Framework
      • 6.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Australia
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Company Market Share/Assessment Analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. SGS Societe Generale de Surveillance SA
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Service Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Labcorp
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Service Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Eurofins Scientific
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Service Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Pace Analytical Services LLC
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Service Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Intertek Group plc
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Service Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. PPD Inc (Thermo Fisher Scientific Inc.)
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Service Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Wuxi AppTec
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Service Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. BA Sciences
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Service Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Charles River Laboratories
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Service Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. West Pharmaceutical Services, Inc
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Service Benchmarking
      • 7.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 4 Global Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 5 Global Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 8 North America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 10 U.S. Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 11 Canada Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 12 Canada Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 13 Mexico Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 14 Mexico Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 15 Europe Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 16 Europe Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 17 Europe Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 18 UK Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 19 UK Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Germany Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 21 Germany Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 22 France Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 23 France Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 24 Italy Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 25 Italy Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 26 Spain Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 27 Spain Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 28 Denmark Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 29 Denmark Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 30 Sweden Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 31 Sweden Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 32 Norway Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 33 Norway Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Japan Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 38 Japan Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 39 China Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 40 China Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 41 India Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 42 India Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 43 Thailand Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 44 Thailand Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 45 South Korea Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 46 South Korea Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 47 Australia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 48 Australia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 49 Latin America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 50 Latin America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 51 Latin America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 52 Brazil Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 53 Brazil Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 54 Argentina Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 55 Argentina Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 59 South Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 60 South Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 63 UAE Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 64 UAE Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 65 Kuwait Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 66 Kuwait Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Pharmaceutical Analytical Testing Outsourcing Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Pharmaceutical Analytical Testing Outsourcing Market: Service outlook and key takeaways
  • Fig. 20 Pharmaceutical Analytical Testing Outsourcing Market: Service movement analysis
  • Fig. 21 Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Others Service Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Pharmaceutical Analytical Testing Outsourcing Market: End Use outlook and key takeaways
  • Fig. 37 Pharmaceutical Analytical Testing Outsourcing Market: End Use movement analysis
  • Fig. 38 Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Contract Research Organizations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Regional Marketplace: Key Takeaways
  • Fig. 42 North America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
  • Fig. 43 Key Country Dynamics
  • Fig. 44 U.S. Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key Country Dynamics
  • Fig. 46 Canada Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key Country Dynamics
  • Fig. 48 Mexico Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Europe Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key Country Dynamics
  • Fig. 51 UK Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key Country Dynamics
  • Fig. 53 Germany Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key Country Dynamics
  • Fig. 55 France Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key Country Dynamics
  • Fig. 57 Italy Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key Country Dynamics
  • Fig. 59 Spain Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key Country Dynamics
  • Fig. 61 Denmark Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key Country Dynamics
  • Fig. 63 Sweden Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 Norway Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 Japan Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 China Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 India Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 Thailand Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key Country Dynamics
  • Fig. 77 South Korea Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key Country Dynamics
  • Fig. 79 Australia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Latin America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key Country Dynamics
  • Fig. 82 Brazil Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key Country Dynamics
  • Fig. 84 Argentina Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 MEA Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key Country Dynamics
  • Fig. 87 South Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key Country Dynamics
  • Fig. 89 Saudi Arabia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key Country Dynamics
  • Fig. 91 UAE Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key Country Dynamics
  • Fig. 93 Kuwait Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key company categorization
  • Fig. 95 Service heat map analysis
  • Fig. 96 Strategic framework